Dr Diego Delgado graduated in Medicine from the Universidad del Salvador in Buenos Aires, Argentina. He completed his Internal Medicine and Cardiology training in Hospital Espanol in Buenos Aires. Subsequently he completed a research fellowship in cardiac transplantation at Rush Presbyterian St Luke’s Medical Center in Chicago, US. He completed a research/clinical fellowship in heart failure and transplantation at the Toronto General Hospital.
Dr. Delgado completed his Maters of Science in Clinical Epidemiology at the University of Toronto and the Leadership Develpment Program at Rotman School of Management in Toronto.
Dr. Delgado holds the Reuben and Florence Fenwick Family Chair in the Medical Management of Heart Failure. Dr. Delgado is a transplant cardiologist, member of the Heart Failure, Transplantation and Mechanical Assist Device Program at University Health Network.
Currently, Dr Delgado is Associate Professor in the Division of Cardiology and Cardiac Transplantation at the University Health Network. Dr Delgado is the Medical Director of the Inpatient Cardiology Service in the Division of Cardiology at the Toronto General Hospital. He is also de Site Director for the Division of Cardiology.
Dr. Delgado is the President of the Interamerican Society of Cardiology and past Chair of the Canadian Cardiac Transplant Group.
He is the author of more than 100 publications in the area of heart failure, transplantation and mechanical assist devices. His interests are immunologic aspects of heart failure and transplantation and cardio oncology.
Industry Expertise (2)
Areas of Expertise (4)
University of Toronto, Rotman School of Management: Certification, Leadership Development Program 2013
University of Toronto: M.S., Clinical Epidemiology 2008
Universidad del Salvador: M.D., Medicine 1994
Media Appearances (2)
For many doctors, stethoscope is still state-of-the-heart technology
The stethoscope slung over Dr. Diego Delgado’s chest is very close to his heart.
“I’m wearing my father’s,” says Delgado, 45, a cardiologist at Toronto’s University Health Network...
Take care of your heart, especially in the winter
January is especially busy for many cardiologists because heart attacks peak around this time of year. We eat and drink more over the holidays, the cold weather hits and our habits change. This can be a dangerous combination of factors for people with pre-existing heart conditions or who have cardiac risk factors. These can include being overweight or obese, having high cholesterol, being inactive or smoking...
Human Leukocyte Antigen-G (HLA-G) is a non-classical class 1b protein, whose gene is located on chromosome 6 (6p21. 31). HLA-G inhibits the immune cells' cytotoxic activity by interacting with specific receptors on their membranes. Since it is a naturally ...
Clonidine may help prevent cardiac complications in patients undergoing non-cardiac surgery and receiving chronic beta-blocker therapy. We conducted a multicentre pilot randomized trial to estimate recruitment rates for a full-scale trial and to assess the safety and tolerability of combining clonidine with chronic beta-blockade...
Autologous stem-cell transplant has been widely used to treat patients with AL amyloidosis. However, transplant-related mortality rates are high, and a recent randomized trial suggested that non-transplant regimens produced comparable results with less ...
The HeartWare ventricular assist device (HVAD) is a new generation centrifugal flow VAD recently introduced in Canada. The objective of this study was to compare the HVAD device to the HeartMate II (HMII) axial flow device. Very few studies have compared ...
Current available treatment options for advanced heart failure include heart transplantation (HTx) and ventricular assist device (VAD) therapy. This project aimed to evaluate the cost-effectiveness of bridge to transplant (BTT)-VAD relative to direct HTx in ...